WallStreetZenWallStreetZen

NASDAQ: MGX
Metagenomi Inc Earnings & Revenue

MGX earnings and revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

MGX Return on Equity

Insufficient data to display

Be the first to know when MGX announces earnings.

MGX Return on Assets

Insufficient data to display

MGX Return on Capital Employed

Current Company
0%
Current Industry
21.4%

MGX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MGXN/AN/AN/AN/AN/A
ORMP$0.00$10.36M$20.86M-100.00%N/A
HOWL$9.28M-$45.18M-$53.73M+49.60%N/A
CKPT$78.00k-$42.47M-$42.47M-55.44%N/A
SEER$14.74M-$76.24M-$82.42M+192.83%N/A

Metagenomi Earnings & Revenue FAQ

What were MGX's earnings last quarter?

Metagenomi (NASDAQ: MGX) reported Q2 2024 earnings per share (EPS) of -$0.29, up 92.41% year over year. Total Metagenomi earnings for the quarter were -$10.74 million. In the same quarter last year, Metagenomi's earnings per share (EPS) was -$3.82.

If you're new to stock investing, here's how to buy Metagenomi stock.

What was MGX's earnings growth in the past year?

As of Q3 2024, Metagenomi's earnings has grown year over year. Metagenomi's earnings in the past year totalled N/A.

What was MGX's revenue last quarter?

Metagenomi (NASDAQ: MGX) reported Q2 2024 revenue of $20.01 million up 76.48% year over year. In the same quarter last year, Metagenomi's revenue was $11.34 million.

What was MGX's revenue growth in the past year?

As of Q3 2024, Metagenomi's revenue has grown null year over year. Metagenomi's revenue in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.